The document discusses the results of a study on the effects of a new drug on memory and cognitive function in older adults. The double-blind study involved 100 participants aged 65-80 who were given either the drug or a placebo daily for 6 months. Results showed those given the drug performed significantly better on memory and problem-solving tests at the end of the study compared to the placebo group, suggesting the drug may help slow cognitive decline in older adults.
